Study ID: GA 9015
Study Title
- Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
Teva Identifier
- GA 9015
ClinicalTrials.gov Identifier
- NCT00203099
Study Status
- Completed
Trial Condition(s)
- Relapse Remitting Multiple Sclerosis
Interventions
- Drug: Glatiramer Acetate, N-Acetylcysteine
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 50 Years
Trial Duration
- 12/01/2004 - 06/01/2008
Phase
- Phase 2
Study Type
Interventional
